Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
Beyond No-Cost Screening: Ensuring Completion of the Colorectal Cancer Screening Continuum after Kennedy v. Braidwood
Jordan Anders-Rumsey1, Uri Ladabaum2, A Mark Fendrick1
1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Abstract:
The 2025 Kennedy v. Braidwood Supreme Court decision upheld the Affordable Care Act mandate requiring insurance coverage of preventive services with an A/B rating from the U.S. Preventive Services Task Force (USPSTF) without cost-sharing. This ruling preserved access to essential preventive care, including colorectal cancer screening, a leading cause of cancer-related mortality despite the availability of effective, evidence-based screening methods. The recent elimination of out-of-pocket costs for follow-up colonoscopy after positive stool testing resulted in an absolute increase of 1.48% in follow-up procedures, highlighting the impact of financial barriers on the completion of the screening continuum. Yet nonfinancial barriers such as limited transportation, language barriers, and scheduling challenges persist. Patient navigation services addressing these barriers have demonstrated substantial improvements in screening adherence and diagnostic completion but remain inconsistently covered. Recent federal policies about breast and cervical cancer screening have expanded the definition of screening to include follow-up care and navigation services, now requiring coverage of these services by private insurers and Medicaid without cost-sharing. Colorectal cancer screening coverage should similarly expand to include these critical support services. Aligning policy with the realities of patient access will enhance screening uptake, reduce disparities, and strengthen the cost-effectiveness of colorectal cancer prevention efforts.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...